clopidogrel has been researched along with proguanil in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Brosen, K; Damkier, P; el Achwah, AB; Nielsen, F; Pedersen, RS; Stage, TB; Vinholt, PJ | 1 |
1 trial(s) available for clopidogrel and proguanil
Article | Year |
---|---|
CYP2C19*17 increases clopidogrel-mediated platelet inhibition but does not alter the pharmacokinetics of the active metabolite of clopidogrel.
Topics: Area Under Curve; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Healthy Volunteers; Humans; Male; Platelet Aggregation; Polymorphism, Single Nucleotide; Proguanil; Prospective Studies; Purinergic P2Y Receptor Antagonists; Substrate Specificity; Ticlopidine; Time Factors | 2014 |
1 other study(ies) available for clopidogrel and proguanil
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |